Specifically, butein treatment significantly alleviated IDD symptoms in diabetic rat models, as evidenced by increased expression of SIRT1 and decreased acetylation levels of p53 within nucleus pulposus tissues (Zh et al., 2019). Here, TP53 is linked to intervertebral disk degenerative disorder.